DHX15 and cancer: The DHX15 silencing significantly affects two networks: (1) endocrine system disorders, organismal injury and abnormalities and cancer, and (2) gastrointestinal disease, organismal injury and abnormalities and carbohydrate metabolism (Supplementary Fig. 6a and b).